BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 176 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $96,316,303 | +4.5% | 637,139 | +0.7% | 8.35% | +27.4% |
| Q2 2022 | $92,204,414 | +20.6% | 632,794 | -1.8% | 6.56% | +11.7% |
| Q1 2022 | $76,438,048 | +76.0% | 644,666 | +104.6% | 5.87% | +111.6% |
| Q4 2021 | $43,427,927 | +162.4% | 315,129 | +30.1% | 2.77% | +123.0% |
| Q1 2021 | $16,552,456 | +86.1% | 242,172 | +133.4% | 1.24% | +19.3% |
| Q4 2020 | $8,893,612 | -57.5% | 103,764 | -67.7% | 1.04% | -77.5% |
| Q3 2020 | $20,905,981 | -36.2% | 321,581 | -28.3% | 4.64% | +3.4% |
| Q2 2020 | $32,772,581 | +805.2% | 448,264 | +321.4% | 4.49% | +399.3% |
| Q1 2020 | $3,620,282 | – | 106,385 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 896,844 | $123,594,000 | 67.92% |
| RP Management, LLC | 1,111,111 | $153,122,000 | 64.09% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,075,402 | $286,011,000 | 40.64% |
| ARS Investment Partners, LLC | 463,392 | $63,860,000 | 5.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 300,373 | $41,394,000 | 4.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 80,348 | $11,073,000 | 4.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,900 | $19,282,000 | 4.30% |
| Avidity Partners Management LP | 1,140,000 | $157,103,000 | 3.33% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $27,562,000 | 3.17% |
| Eventide Asset Management | 1,635,000 | $225,319,000 | 2.88% |